[Retracted] Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer

Table 1

KEGG pathways (top 20) associated with the differentially expressed genes between TCGA-PAAD tumor tissues with high and low prognostic risk scores.

Description	Set size	ES	NES	value
KEGG_PATHWAYS_IN_CANCER	320	−0.45	−1.87	1.29E − 03
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	206	−0.44	−1.76	1.39E − 03
KEGG_FOCAL_ADHESION	199	−0.48	−1.90	1.40E − 03
KEGG_AXON_GUIDANCE	128	−0.44	−1.65	1.49E − 03
KEGG_TIGHT_JUNCTION	129	−0.49	−1.84	1.49E − 03
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	110	−0.50	−1.85	1.51E − 03
KEGG_CELL_CYCLE	124	−0.55	−2.02	1.53E − 03
KEGG_PYRIMIDINE_METABOLISM	95	−0.42	−1.50	1.54E − 03
KEGG_SMALL_CELL_LUNG_CANCER	84	−0.55	−1.95	1.59E − 03
KEGG_ECM_RECEPTOR_INTERACTION	82	−0.61	−2.13	1.59E − 03
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	74	−0.51	−1.77	1.63E − 03
KEGG_ADHERENS_JUNCTION	73	−0.56	−1.94	1.64E − 03
KEGG_PANCREATIC_CANCER	70	−0.53	−1.81	1.64E − 03
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	67	−0.56	−1.91	1.64E − 03
KEGG_P53_SIGNALING_PATHWAY	68	−0.53	−1.79	1.66E − 03
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	54	−0.59	−1.93	1.68E − 03
KEGG_GLYCOLYSIS_GLUCONEOGENESIS	57	−0.52	−1.69	1.70E − 03
KEGG_PROTEASOME	43	−0.71	−2.17	1.73E − 03
KEGG_O_GLYCAN_BIOSYNTHESIS	29	−0.60	−1.71	1.75E − 03
KEGG_BLADDER_CANCER	42	−0.62	−1.89	1.76E − 03

NES, normalized enrichment score. ES, enrichment score. overlapping pathways between GSEA and clusterProfiler functional enrichment analysis.